Ausgabe 10/2017
Inhalt (16 Artikel)
Clinical benefit of antiangiogenic therapy in advanced and metastatic chondrosarcoma
Robin L. Jones, Daniela Katz, Elizabeth T. Loggers, Darin Davidson, Eve T. Rodler, Seth M. Pollack
Correlation of early PET findings with tumor response to molecular targeted agents in patients with advanced driver-mutated non-small cell lung cancer
Tomonobu Koizumi, Toshirou Fukushima, Daisuke Gomi, Takashi Kobayashi, Nodoka Sekiguchi, Keiko Mamiya, Kazunari Tateishi, Akane Katou, Kazuhiro Oguchi
Induction of antitumor response to fibrosarcoma by Newcastle disease virus-infected tumor vaccine
Mai Takamura-Ishii, Takahiro Miura, Takaaki Nakaya, Katsuro Hagiwara
Fluorescence in situ hybridization as prognostic predictor of tumor recurrence during treatment with Bacillus Calmette–Guérin therapy for intermediate- and high-risk non-muscle-invasive bladder cancer
Esmee I. M. L. Liem, Joyce Baard, Evelyne C. C. Cauberg, Mieke T. J. Bus, D. Martijn de Bruin, M. Pilar Laguna Pes, Jean J. M. C. H. de la Rosette, Theo M. de Reijke
Personalized ex vivo multiple peptide enrichment and detection of T cells reactive to multiple tumor-associated antigens in prostate cancer patients
Pavla Taborska, Dmitry Stakheev, Zuzana Strizova, Katerina Vavrova, Michal Podrazil, Jirina Bartunkova, Daniel Smrz
Yttrium-90 radioembolization treatment for unresectable hepatocellular carcinoma: a single-centre prognostic factors analysis
C. Floridi, F. Pesapane, S. A. Angileri, D. De Palma, F. Fontana, F. Caspani, A. Barile, A. Del Sole, C. Masciocchi, G. Lucignani, G. Carrafiello
EGFR and KRAS mutations do not enrich for the activation of IL-6, JAK1 or phosphorylated STAT3 in resected lung adenocarcinoma
Timothy D. Clay, Prudence A. Russell, Hongdo Do, Vijaya Sundararajan, Matthew Conron, Gavin M. Wright, Benjamin Solomon, Alexander Dobrovic, Sue-Anne McLachlan, Melissa M. Moore
Molecular modeling and structure-based drug discovery approach reveals protein kinases as off-targets for novel anticancer drug RH1
Pramodkumar P. Gupta, Virupaksha A. Bastikar, Dalius Kuciauskas, Shanker Lal Kothari, Jonas Cicenas, Mindaugas Valius
Theoretical method for evaluation of therapeutic effects and adverse effects of epidermal growth factor receptor tyrosine kinase inhibitors in clinical treatment
Koji Kimura, Risa Takayanagi, Tomoki Fukushima, Yasuhiko Yamada
Checkpoint inhibitors: the new treatment paradigm for urothelial bladder cancer
Heather Katz, Emnet Wassie, Mohamed Alsharedi
Pre-treatment carcinoembryonic antigen and outcome of patients with rectal cancer receiving neo-adjuvant chemo-radiation and surgical resection: a systematic review and meta-analysis
Giuseppe Colloca, Antonella Venturino, Pasquale Vitucci
Genetic susceptibility in childhood acute lymphoblastic leukemia
Angela Gutierrez-Camino, Idoia Martin-Guerrero, Africa García-Orad
Notch signaling pathway networks in cancer metastasis: a new target for cancer therapy
Li Li, Ping Tang, Shun Li, Xiang Qin, Hong Yang, Chunhui Wu, Yiyao Liu
Low dose versus standard dose of corticosteroids in the management of adverse events of special interest from abiraterone acetate: data from a literature-based meta-analysis
Giandomenico Roviello, Silvia Paola Corona, Daniele Generali
Interleukin-8 and nuclear factor kappa B are increased and positively correlated in myelodysplastic syndrome
Anacélia Gomes de Matos, Howard Lopes Ribeiro Junior, Daniela de Paula Borges, Bruno Memória Okubo, Juliana Cordeiro de Sousa, Maritza Cavalcante Barbosa, Marilena Facundo de Castro, Romélia Pinheiro Gonçalves, Ronald Feitosa Pinheiro, Silvia Maria Meira Magalhães
Retraction Note to: Metabolic syndrome factors and risk of postoperative depression in high-grade glioma patients in a 1.5-year prospective study
Jian-tong Jiao, Chen Jiang, Jin Huang, Min-chao Dai, Cheng Wang, Chao Cheng, Jun-fei Shao